BACKGROUND: Therapeutic hypothermia can improve survival after cardiopulmonary resuscitation (CPR). Coenzyme Q10 (CoQ10) has shown a protective effect in neurodegenerative disorders. We investigated whether combining mild hypothermia with CoQ10 after out-of-hospital cardiac arrest provides additional benefit. METHODS AND RESULTS:Forty-nine patients were randomly assigned to either hypothermia plus CoQ10 or hypothermia plus placebo after CPR. Hypothermia with a core temperature of 35 degrees C was instituted for 24 hours. Liquid CoQ10 250 mg followed by 150 mg TID for 5 days or placebo was administered through nasogastric tube. Age, sex, premorbidity, cause of arrest, conditions of CPR, and degree of hypoxia were similar in both groups; no side effects of CoQ10 were identified. Three-month survival in the CoQ10 group was 68% (17 of 25) and 29% (7 of 24) in the placebo group (P=0.0413). Nine CoQ10 patients versus 5 placebo patients survived with a Glasgow Outcome Scale of 4 or 5. Mean serum S100 protein 24 hours after CPR was significantly lower in the CoQ10 group (0.47 versus 3.5 ng/mL). CONCLUSIONS: Combining CoQ10 with mild hypothermia immediately after CPR appears to improve survival and may improve neurological outcome in survivors.
RCT Entities:
BACKGROUND: Therapeutic hypothermia can improve survival after cardiopulmonary resuscitation (CPR). Coenzyme Q10 (CoQ10) has shown a protective effect in neurodegenerative disorders. We investigated whether combining mild hypothermia with CoQ10 after out-of-hospital cardiac arrest provides additional benefit. METHODS AND RESULTS: Forty-nine patients were randomly assigned to either hypothermia plus CoQ10 or hypothermia plus placebo after CPR. Hypothermia with a core temperature of 35 degrees C was instituted for 24 hours. Liquid CoQ10 250 mg followed by 150 mg TID for 5 days or placebo was administered through nasogastric tube. Age, sex, premorbidity, cause of arrest, conditions of CPR, and degree of hypoxia were similar in both groups; no side effects of CoQ10 were identified. Three-month survival in the CoQ10 group was 68% (17 of 25) and 29% (7 of 24) in the placebo group (P=0.0413). Nine CoQ10patients versus 5 placebo patients survived with a Glasgow Outcome Scale of 4 or 5. Mean serum S100 protein 24 hours after CPR was significantly lower in the CoQ10 group (0.47 versus 3.5 ng/mL). CONCLUSIONS: Combining CoQ10 with mild hypothermia immediately after CPR appears to improve survival and may improve neurological outcome in survivors.
Authors: Michael N Cocchi; Brandon Giberson; Katherine Berg; Justin D Salciccioli; Ali Naini; Catherine Buettner; Praveen Akuthota; Shiva Gautam; Michael W Donnino Journal: Resuscitation Date: 2012-03-28 Impact factor: 5.262
Authors: Romergryko G Geocadin; Eelco Wijdicks; Melissa J Armstrong; Maxwell Damian; Stephan A Mayer; Joseph P Ornato; Alejandro Rabinstein; José I Suarez; Michel T Torbey; Richard M Dubinsky; Jason Lazarou Journal: Neurology Date: 2017-05-10 Impact factor: 9.910
Authors: Obaida R Rana; Jörg W Schröder; Julia S Kühnen; Esra Saygili; Christopher Gemein; Matthias D H Zink; Patrick Schauerte; Johannes Schiefer; Robert H G Schwinger; Joachim Weis; Nikolaus Marx; Malte Kelm; Christian Meyer; Erol Saygili Journal: Clin Res Cardiol Date: 2012-02-10 Impact factor: 5.460
Authors: Stephen Trzeciak; Alan E Jones; J Hope Kilgannon; Brian M Fuller; Brian W Roberts; Joseph E Parrillo; John T Farrar Journal: Resuscitation Date: 2009-04-21 Impact factor: 5.262
Authors: Jerry P Nolan; Claudio Sandroni; Bernd W Böttiger; Alain Cariou; Tobias Cronberg; Hans Friberg; Cornelia Genbrugge; Kirstie Haywood; Gisela Lilja; Véronique R M Moulaert; Nikolaos Nikolaou; Theresa Mariero Olasveengen; Markus B Skrifvars; Fabio Taccone; Jasmeet Soar Journal: Intensive Care Med Date: 2021-03-25 Impact factor: 17.440